Date: February 13, 2018
Medical Disposables & Supplies Limited, for the nine months ended December 31, 2017, reported revenue amounted to $1.49 billion, an increase of 18% when compared with the $1.26 billion booked last year. Revenue for the quarter totaled $521.10 million up 21% year over year (2016: $431.93 million). MDS stated that this performance was due to “increased sales in all divisions of the business operations.”
Cost of sales rose by 23% to total $399.88 million during the quarter relative to the $325.82 million reported for the same period last year. For the nine months period, cost of sales increased by 21% to $1.16 billion (2016: $954.96 million). Consequently, gross profit increased 14% or $15.11 million to a total of $121.21 million in the quarter relative to the $106.11 million for the corresponding period in 2016. There was a 9% increase in gross profit for the nine months period as compared to prior year. The company highlighted that “this improvement in the gross profit was driven by increased sales as a result of new business lines.”
Total operating cost closed the period at $247.64 million, up 17% (2016: $211.10 million). Of this selling and promotional costs increased 29% to $98.48 million (2016: $76.37 million) Administrative expenses increased by 13% to $130.13 million from $115.08 million last year. This was as a result of “increases in staff-related expenses, professional fees, marketing expenses, transportation and delivery, insurance, utilities and security expenses”.
Gain on foreign exchange was reported at $4.68 million compared a loss of $2.12 million in 2016. Finance Cost decreased by $171,000 to total $26.44 million. (2016: $26.61 million) .
As a result, MDS reported profit before tax of $63.52 million, a 5% decrease relative to the $66.86 million reported in 2016.
Consequently, net profit for the period amounted to $63.46 million relative to $66.80 million in 2016, a 5% decline year over year, after a tax charge of $60,000 for the 2017 period. Net profit for the quarter amounted to $31.89 million (2016: $29.23 million).
Earnings per share for the period amounted $0.24 (2016: $0.25). EPS for the quarter amounted to $0.12 relative to $0.11 in 2016. The trailing-twelve-month EPS amounted to $0.37. The number of shares used in the calculations is 263,157,895.
MDS closed February 13, 2018, at $5.00.
Balance Sheet at a glance:
As at December 2017, total assets amounted to $1.36 billion, 15% more than $1.12 billion the year prior. The company noted that, “this was as a result of increased inventories and receivables balances generated from the introduction of new business lines which resulted in the overall increase in sales revenue.”
Shareholders’ Equity totaled $627 million (2016: $530.34 million) resulting in a book value per share of $2.38 (2016: $2.02).
The information contained herein has been obtained from sources believed to be reliable, however its accuracy and completeness cannot be guaranteed. You are hereby notified that any disclosure, copying, distribution or taking any action in reliance on the contents of this information is strictly prohibited and may be unlawful. Mayberry may effect transactions or have positions in securities mentioned herein. In addition, employees of Mayberry may have positions and effect transactions in the securities mentioned herein.
